Laurus Labs Share Price Live
Live Laurus Labs Share Price Chart
O H L VOL
Laurus Labs Performance
Laurus Labs Shareholding Pattern
Data is not available currently. Please check back later.
Laurus Labs Fundamentals
| ROCE(TTM) | 5.36 |
|---|---|
| P/E Ratio (TTM) | 235.68 |
| P/B Ratio | 7.47 |
| Industry P/E | 37.61 |
| Debt to Equity | 0.67 |
| ROE | 3.17 |
| EPS (TTM) | 2.43 |
| Dividend Yield | 0.14 |
| Book Value | 76.67 |
| Face Value | 2 |
| ROCE(TTM) | 5.36 |
|---|---|
| P/E Ratio (TTM) | 235.68 |
| P/B Ratio | 7.47 |
| Industry P/E | 37.61 |
| Debt to Equity | 0.67 |
| ROE | 3.17 |
|---|---|
| EPS (TTM) | 2.43 |
| Dividend Yield | 0.14 |
| Book Value | 76.67 |
| Face Value | 2 |
Laurus Labs Financials
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
|---|---|---|---|---|
| Net Sales | 1,194.92 | 1,439.67 | 1,194.91 | 1,223.70 |
| Expenses | 1,111.91 | 1,300.43 | 1,129.77 | 1,152.88 |
| Profit before tax | 34.62 | 107.27 | 18.46 | 22.81 |
| Operating Profit | 25.17 | 75.32 | 12.21 | 17.72 |
| Net Profit | 25.17 | 75.32 | 12.21 | 17.72 |
| ESP in Rs | 0.43 | 1.40 | 0.23 | 0.37 |
Community Discussion
No comments found
Be the first one to start a discussion
Popular stocks
Laurus Labs Ltd FAQs
What is the share price of Laurus Labs Ltd (LAURUSLABS) shares?
Laurus Labs Ltd (LAURUSLABS) share price as of December 20, 2024, on NSE is Rs 559.2 (NSE) and Rs 559.2 (BSE) on BSE.
Can I buy Laurus Labs Ltd (LAURUSLABS) from Angel One?
Yes, You can buy Laurus Labs Ltd (LAURUSLABS) shares by opening a Demat account with Angel One.
How do I buy Laurus Labs Ltd (LAURUSLABS) from Angel One?
Laurus Labs Ltd (LAURUSLABS) share can be bought through the following modes:
1. Direct investment: You can buy Laurus Labs Ltd (LAURUSLABS) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Laurus Labs Ltd (LAURUSLABS) shares.
1. Direct investment: You can buy Laurus Labs Ltd (LAURUSLABS) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Laurus Labs Ltd (LAURUSLABS) shares.
What is the main business of Laurus Labs?
The main business of Laurus Labs is to research, manufacture, and sell pharmaceutical and biotechnology-related products with a special emphasis on Hepatitis C, anti-retroviral, and oncology drugs. It also sells its generic APIs in 56 countries along with generic FDF.
Who are the promoters of Laurus Labs?
Some of the main promoters of Laurus Labs are M/s. NSN Holdings (Represented by its Managing Partner, Dr. Satyanarayana Chava), Chava Naga Rani, Satyanarayana Chava, Chunduru Venkata Lakshmana Rao, Venkata Ravi Kumar Vantaram, Hymavathi Vantaram, Rama Suryadevara, and Krishnaveni Vasireddi.
What are the Subsidiaries that comes under Laurus Labs?
The main subsidiaries that come under Laurus Labs are Laurus Generics Inc., USA, Sriram Labs Pvt. Ltd., Laurus Holdings Ltd., Laurus Ingredients Pvt. Ltd., Laurus Generics Gmbh, Laurus Generics SA (Pty) Ltd., and Laurus Bio Private Ltd. (formerly known as Richcore Lifesciences Pvt. Ltd.).